BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22025255)

  • 1. Neuropilin-1 expression in cancer and development.
    Jubb AM; Strickland LA; Liu SD; Mak J; Schmidt M; Koeppen H
    J Pathol; 2012 Jan; 226(1):50-60. PubMed ID: 22025255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
    Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
    Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma.
    Osada H; Tokunaga T; Nishi M; Hatanaka H; Abe Y; Tsugu A; Kijima H; Yamazaki H; Ueyama Y; Nakamura M
    Anticancer Res; 2004; 24(2B):547-52. PubMed ID: 15160992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
    Pan Q; Chanthery Y; Liang WC; Stawicki S; Mak J; Rathore N; Tong RK; Kowalski J; Yee SF; Pacheco G; Ross S; Cheng Z; Le Couter J; Plowman G; Peale F; Koch AW; Wu Y; Bagri A; Tessier-Lavigne M; Watts RJ
    Cancer Cell; 2007 Jan; 11(1):53-67. PubMed ID: 17222790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling.
    Bergé M; Allanic D; Bonnin P; de Montrion C; Richard J; Suc M; Boivin JF; Contrerès JO; Lockhart BP; Pocard M; Lévy BI; Tucker GC; Tobelem G; Merkulova-Rainon T
    J Hepatol; 2011 Oct; 55(4):866-75. PubMed ID: 21338642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation.
    Halder JB; Zhao X; Soker S; Paria BC; Klagsbrun M; Das SK; Dey SK
    Genesis; 2000 Mar; 26(3):213-24. PubMed ID: 10705382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
    Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
    Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropilin-2 expression in cancer.
    Jubb AM; Sa SM; Ratti N; Strickland LA; Schmidt M; Callahan CA; Koeppen H
    Histopathology; 2012 Sep; 61(3):340-9. PubMed ID: 22384800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer.
    Staton CA; Koay I; Wu JM; Hoh L; Reed MW; Brown NJ
    Histopathology; 2013 May; 62(6):908-15. PubMed ID: 23551578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
    Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
    Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.
    Saban MR; Sferra TJ; Davis CA; Simpson C; Allen A; Maier J; Fowler B; Knowlton N; Birder L; Wu XR; Saban R
    Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1245-56. PubMed ID: 20861073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preserved expression of neuropilin (NRP) 1 contributes to a better prognosis in colon cancer.
    Kamiya T; Kawakami T; Abe Y; Nishi M; Onoda N; Miyazaki N; Oida Y; Yamazaki H; Ueyama Y; Nakamura M
    Oncol Rep; 2006 Feb; 15(2):369-73. PubMed ID: 16391856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
    Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis.
    Achen MG; Williams RA; Minekus MP; Thornton GE; Stenvers K; Rogers PA; Lederman F; Roufail S; Stacker SA
    J Pathol; 2001 Feb; 193(2):147-54. PubMed ID: 11180159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.